Nearly every company begins with a simple financial setup. In the earliest phase, spreadsheets feel practical and efficient. Revenue is limited, expenses are ...

The challenge for CFOs and other leaders is to develop a culture of financial literacy across the organization without taking on additional long-term roles as educators.

Charlene Rhinehart is a CPA , CFE, chair of an Illinois CPA Society committee, and has a degree in accounting and finance from DePaul University. The balance sheet equation is Assets = Liabilities + ...

Network‑1 Technologies, Inc. (NYSE American:NTIP) ("Network‑1"), a company specializing in the acquisition, development, licensing and monetization of its intellectual property assets, today announced ...

Parex Resources Inc. (“Parex” or the “Company”) (TSX: PXT) is pleased to announce that it has entered into a definitive agreement (the "Arrangement Agreement") with Frontera Energy Corporation ...

Nektar Therapeutics (Nasdaq: NKTR) today reported financial results for the fourth quarter ended December 31, 2025.

Autoscope Technologies Corporation ("AATC" or the "Company") (OTCQX: AATC) today announced results for the quarter and year ended December 31, 2025. Fourth ...

Ramp reports that separating business and personal bank accounts is crucial to avoid legal, tax, and credibility risks for ...

EverCommerce Inc. ("EverCommerce" or the "Company") (NASDAQ: EVCM), a leading AI-powered platform helping service SMBs run smarter and grow faster, announced today financial results for the quarter ...

NEW CANAAN, CT / ACCESS Newswire / March 13, 2026 / Network-1 Technologies, Inc. (NYSE American:NTIP) ("Network-1"), a company specializing in the acquisition, development, licensing and monetization ...

HARRISBURG, Pa., March 12, 2026 (GLOBE NEWSWIRE) -- Ollie's Bargain Outlet Holdings, Inc. (NASDAQ: OLLI) (the "Company") today announced financial results for the fourth quarter and fiscal year ended ...

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with ...